Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefewel
Cefewel is a potent, broad-spectrum antibiotic containing Cefepime, designed to treat severe bacterial infections. As a fourth-generation cephalosporin, it provides enhanced antibacterial coverage, including against resistant strains.
Uses of Cefewel
Treatment of severe bacterial infections, including pneumonia and sepsis.
Effective in urinary tract infections (UTIs) and skin infections.
Used for intra-abdominal and hospital-acquired infections.
Preferred antibiotic for multidrug-resistant bacterial infections.
Benefits of Cefewel
Strong activity against a wide range of bacteria.
Highly effective in hospital settings for critical infections.
Rapid onset of action with IV or IM administration.
Well-tolerated with proven clinical efficacy.
Mechanism of Action of Cefewel
Inhibits bacterial cell wall synthesis, leading to bacterial death.
Highly resistant to beta-lactamases, making it effective against resistant bacteria.
Provides extended antibacterial coverage compared to earlier cephalosporins.
Note: Cefewel should be administered only under the guidance of a healthcare professional. Proper dosing and renal function monitoring are recommended to ensure safety and effectiveness.